The document discusses the importance of preclinical pharmacological studies in drug development, which involves research conducted before human clinical trials to assess drug safety, efficacy, and potential toxicity, primarily using laboratory animals. It outlines various animal models, methodologies, and assays used to evaluate drug candidates, including behavioral models and biochemical tests, to provide necessary data for FDA submissions. The role of preclinical studies in determining dosage, identifying lead candidates, and ensuring the safety of new drugs is emphasized.